Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement

Xie, Feng; Li, Shu Chuen; Goeree, Ron; Tarride, Jean‐Éric; O’Reilly, Daria; Lo, Ngai-Nung; Yeo, Seng-Jin; Yang, Kuang-Ying; Thumboo, Julian

doi:10.1007/s11136-008-9340-7

Cited by 101 publications

(93 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Chinese version of the WOMAC osteoarthritis (OA) indexes, shown to be valid and reliable for evaluating KOA pain and dysfunction, were used at baseline and follow-up assessments during the 24-week study period [14]. All patients were allowed to maintain their baseline pain medications during the course of treatment.…”

Section: Methodsmentioning

confidence: 99%

Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

et al. 2014

View full text Add to dashboard Cite

IntroductionOur objective was to compare the effectiveness and safety of traditional Chinese moxibustion to that of sham moxibustion in patients with chronic knee osteoarthritis (KOA) pain.MethodsWe conducted a randomized placebo-controlled trial involving 110 patients with KOA who met the inclusion criteria. These patients randomly received either active moxibustion (n = 55) or sham moxibustion control (n = 55) at acupoints Dubi (ST 35), extra-point Neixiyan (EX-LE 4), and an Ashi (tender) point three times a week for 6 weeks. Effects were evaluated with Western Ontario and McMaster Universities’ Osteoarthritis Index (WOMAC VA 3.1) criteria at the end of the course of treatment and 3, 12, and 24 weeks after the initial treatment.ResultsThe WOMAC pain scores showed greater improvement in the active treatment group than in control at weeks 3 (P = 0.012), 6 (P <0.001), 12 (P = 0.002), and 24 (P = 0.002) as did WOMAC physical function scores of the active treatment group at week 3 (P = 0.002), 6 (P = 0.015), and 12 (P <0.001) but not 24 (P = 0.058). Patients and practitioners were blinded successfully, and no significant adverse effects were found during the trial.ConclusionsA 6-week course of moxibustion seems to relieve pain effectively and improve function in patients with KOA for up to 18 weeks after the end of treatment. Moxibustion treatment appears to be safe, and the usefulness of the novel moxa device was validated.Trial registrationCurrent controlled trial: ISRCTN68475405. Registered 4 April 2014.

show abstract

Section: Methodsmentioning

confidence: 99%

Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

et al. 2014

View full text Add to dashboard Cite

show abstract

“…12,13 In addition, their respective Chinese translations were available. 12,13 The WOMAC Osteoarthritis Index was initially designed to evaluate the severity of joint osteoarthritis. However, its application in measuring the patellofemoral pain level is not rare.…”

Section: Discussionmentioning

confidence: 99%

Chinese adaptation and validation of the patellofemoral pain severity scale

Cheung

Ngai

Lam³

et al. 2012

Clin Rehabil

View full text Add to dashboard Cite

show abstract

“…In addition, validity was analyzed according to (i) factor analysis to ensure replication of the original factor pattern and principal component analysis with varimax rotation as done in similar studies previously [18]. (ii) Item-to-domain correlation was assessed using Spearman's rank correlations (r s ) between domains and their constituent items, where r s > 0.4 was considered to be Bacceptable^ [19]. A response analysis was undertaken for the KBD patients who accepted intra-articular injection of sodium hyaluronate, and pre-treatment and post-treatment scores were measured using the JDI scale.…”

Section: Measurement Model Testmentioning

confidence: 99%

Reliability and validation of the joint dysfunction index as a new assessment instrument for therapeutic efficacy for Kashin-Beck disease

Xia

Hua

et al. 2016

Clin Rheumatol

View full text Add to dashboard Cite

The objective of this study was to evaluate the reliability and validity of the joint dysfunction index (JDI) for assessment of therapeutic efficacy for Kashin-Beck disease (KBD). In an initial survey, completed questionnaires were obtained from 276 of 281 patients (98.2 %). A follow-up survey was completed with 64 KBD patients among 276 cases. A third survey selected 60 KBD patients who underwent intra-articular injection of sodium hyaluronate in the knees ascertained from the findings of the second questionnaire. Reliability was assessed using test-retest, "split-half" reliability and Cronbach's alpha coefficient. Factor analysis and item-to-domain correlation were used to analyze validity. The coefficient of variation (CV) was used to measure the sensitivity of scale. Feasibility assessment included consideration of completion time, rate of recovery, and time of completion. Reliability analysis comprised a test-retest correlation coefficient of 0.404-0.546 and a kappa test of 0.404-0.546. Internal consistency analysis comprised a Cronbach alpha coefficient of 0.689 and a split-half coefficient of 0.677. Principal component factor analysis for validity testing extracted a common factor with a cumulative variance contribution of 45.44 %. The JDI score from 276 KBD cases revealed no significant difference associated with age, gender, education, or the body mass index. Sensitivity analysis showed that there was no significant difference between pre-treatment and post-treatment values, with a CV of 96.55-172.06 %. In conclusion, the JDI can be used to evaluate the efficacy of agents used to treat KBD.

show abstract

Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement

Abstract: Chinese WOMAC was well accepted and demonstrated acceptable psychometric properties in Singaporean patients with severe knee OA.

Cited by 101 publications

References 11 publications

Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

Effectiveness of moxibustion treatment as adjunctive therapy in osteoarthritis of the knee: a randomized, double-blinded, placebo-controlled clinical trial

Chinese adaptation and validation of the patellofemoral pain severity scale

Reliability and validation of the joint dysfunction index as a new assessment instrument for therapeutic efficacy for Kashin-Beck disease

Contact Info

Product

Resources

About